Financial results - REVOLVE PHARMA SRL

Financial Summary - Revolve Pharma Srl
Unique identification code: 28992987
Registration number: J2011009888405
Nace: 4646
Sales - Ron
553.299
Net Profit - Ron
238.813
Employees
5
Open Account
Company Revolve Pharma Srl with Fiscal Code 28992987 recorded a turnover of 2022 of 553.299, with a net profit of 238.813 and having an average number of employees of 5. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Revolve Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 46.605 82.660 180.673 322.410 180.491 533.390 376.059 558.101 - -
Total Income - EUR 46.634 83.674 180.781 323.008 180.719 535.952 380.012 567.529 - -
Total Expenses - EUR 84.208 157.243 158.166 202.255 165.212 344.610 222.621 321.826 - -
Gross Profit/Loss - EUR -37.574 -73.568 22.615 120.753 15.508 191.342 157.391 245.703 - -
Net Profit/Loss - EUR -37.623 -74.404 20.807 117.741 13.701 185.988 154.552 240.886 - -
Employees 5 8 10 8 7 7 5 5 - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 47.9%, from 376.059 euro in the year 2021, to 558.101 euro in 2022. The Net Profit increased by 85.854 euro, from 154.552 euro in 2021, to 240.886 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Revolve Pharma Srl

Rating financiar

Financial Rating -
REVOLVE PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Revolve Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Revolve Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Revolve Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Revolve Pharma Srl - CUI 28992987

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.160 3.006 29.704 30.805 27.181 20.881 60.403 136.860 - -
Current Assets 98.009 93.733 102.554 166.409 188.223 406.854 625.945 717.119 - -
Inventories 66.002 39.405 46.197 8.240 15.497 48.815 31.611 40.765 - -
Receivables 21.554 25.153 33.938 63.618 86.088 314.178 480.526 491.001 - -
Cash 10.453 29.174 22.420 94.551 86.638 43.861 113.808 185.353 - -
Shareholders Funds 5.496 -69.189 -47.211 71.397 83.716 268.117 416.723 584.196 - -
Social Capital 45 45 44 43 42 41 40 41 - -
Debts 93.673 165.928 179.468 125.817 131.689 159.619 269.625 269.782 - -
Income in Advance 0 0 0 0 0 0 0 0 - -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 717.119 euro in 2022 which includes Inventories of 40.765 euro, Receivables of 491.001 euro and cash availability of 185.353 euro.
The company's Equity was valued at 584.196 euro, while total Liabilities amounted to 269.782 euro. Equity increased by 166.180 euro, from 416.723 euro in 2021, to 584.196 in 2022.

Risk Reports Prices

Reviews - Revolve Pharma Srl

Comments - Revolve Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.